Cargando…
The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target
p53 is a sequence-specific short-lived transcription factor expressed at low concentrations in various tissues while it is upregulated in damaged, tumoral or inflamed tissue. In normally proliferating cells, p53 protein levels and function are tightly controlled by main regulators, i.e., MDM2 (mouse...
Autores principales: | Fierabracci, Alessandra, Pellegrino, Marsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187775/ https://www.ncbi.nlm.nih.gov/pubmed/27897991 http://dx.doi.org/10.3390/ijms17121975 |
Ejemplares similares
-
Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
por: Gianchecchi, Elena, et al.
Publicado: (2021) -
Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
por: Gianchecchi, Elena, et al.
Publicado: (2021) -
Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients
por: Pellegrino, Marsha, et al.
Publicado: (2020) -
p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity
por: Arena, Andrea, et al.
Publicado: (2021) -
Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity
por: Gianchecchi, Elena, et al.
Publicado: (2020)